Two experiments were performed, in which male Wistar Walker 256 tumor-bearing rats were inoculated with 4 × 107 tumor cells subcutaneously and received either creatine (300 mg/kg body weight/day; CR) or placebo (water; PL) supplementation via intragastric gavage. In experiment 1, 50 rats were given PL (n = 22) or CR (n = 22) and a non-supplemented, non-inoculated group served as control CT (n = 6), for 40 days, and the survival rate and tumor mass were assessed. In experiment 2, 25 rats were given CR or PL for 15 days and sacrificed for biochemical analysis. Again, a non-supplemented, non-inoculated group served as control (CT; n = 6). Tumor and muscle creatine kinase (CK) activity and total creatine content, acidosis, inflammatory cytokines, and antioxidant capacity were assessed. Tumor growth was significantly reduced by approximately 30 % in CR when compared with PL (p = 0.03), although the survival rate was not significantly different between CR and PL (p = 0.65). Tumor creatine content tended to be higher in CR than PL (p = 0.096). Tumor CK activity in the cytosolic fraction was higher in CR than PL (p < 0.0001). Blood pCO2 was higher in CT and CR than PL (p = 0.0007 and p = 0.004, respectively). HCO3 was augmented in CT compared to PL (p = 0.03) and CR (p = 0.001). Plasma IL-6 was lower and IL-10 level was higher in CR than PL (p = 0.03 and p = 0.0007, respectively) and TNF-alpha featured a tendency of decrease in CR compared to PL (p = 0.08). Additionally, total antioxidant capacity tended to be lower in CT than PL (p = 0.07). Creatine supplementation was able to slow tumor growth without affecting the overall survival rate, probably due to the re-establishment of the CK-creatine system in cancer cells, leading to attenuation in acidosis, inflammation, and oxidative stress. These findings support the role of creatine as a putative anti-cancer agent as well as help in expanding our knowledge on its potential mechanisms of action in malignancies.
Diet Supplementation Tumor Malignancy
CO2 partial pressure
This is a preview of subscription content, log in to check access.
The authors are grateful to Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 12/02682-9;12/50079-0).
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
Research involving animals
Our experimental protocol has been approved by the local Ethics Committee on Research (Of. CEP/03511/EEFE/30.05.2011). This study was conducted under the standards of the Brazilian College of Animal Experimentation (COBEA).
Alves C et al (2012) No effect of creatine supplementation on oxidative stress and cardiovascular parameters in spontaneously hypertensive rats. J Int Soc Sports Nutr 9:1–4. doi:10.1186/1550-2783-9-13CrossRefGoogle Scholar
Avila-Díaz M et al (2006) Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 26:574–580PubMedGoogle Scholar
Bergnes G, Yuan W, Khandekar V, OKeefe M, Martin K, Teicher B, KaddurahDaouk R (1996) Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. Oncol Res 8:121–130PubMedGoogle Scholar
Bodin P, Burnstock G (1998) Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 47:351–354CrossRefPubMedGoogle Scholar
Deminice R, Rosa FT, Franco GS, Jordao AA, de Freitas EC (2013) Effects of creatine supplementation on oxidative stress and inflammatory markers after repeated-sprint exercise in humans. Nutrition 29:1127–1132. doi:10.1016/j.nut.2013.03.003CrossRefPubMedGoogle Scholar
Guimaraes-Ferreira L, Pinheiro C, Gerlinger-Romero F, Vitzel K, Nachbar R, Curi R, Nunes M (2012) Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle. Eur J Appl Physiol 112:3905–3911. doi:10.1007/s00421-012-2378-9CrossRefPubMedGoogle Scholar
Koetting J, Henninger C, Drevs A, MaierLenz H, Sonntag O (1996) Activity of creatine-kinase (CK) and subunit CK-MB in patients with different high malignant tumor diseases. Clin Chem 42:674Google Scholar
Kornacker M et al (2001) Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis. Int J Cancer 94:513–519CrossRefPubMedGoogle Scholar
Lillie JW, O’Keefe M, Valinski H, Hamlin HA, Varban ML, Kaddurah-Daouk R (1993) Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res 53:3172–3178PubMedGoogle Scholar
Machado AP, Costa Rosa LF, Seelaender MC (2004) Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltration. Cell Tissue Res 318:503–514. doi:10.1007/s00441-004-0987-2CrossRefPubMedGoogle Scholar
Martin K, Chen S, Clark G, Degen D, Wajima M, Vonhoff D, Kaddurahdaouk R (1994) Evaluation of creatine analogs as a new class of anticancer agents using freshly explanted human tumor-cells. J Natl Cancer Inst 86:608–613. doi:10.1093/jnci/86.8.608CrossRefPubMedGoogle Scholar
Ohira Y, Inoue N (1995) Effects of creatine and beta-guanidinopropionic acid on the growth of Erlich ascites tumor-cells—IP injection and culture study. Biochim Biophys Acta Gen Subj 1243:367–372. doi:10.1016/0304-4165(94)00161-PCrossRefGoogle Scholar
Pereira RT, Porto CS, Abdalla FM (2014) Ovariectomy and 17β-estradiol replacement play a role on the expression of endonuclease-G and phosphorylated cyclic AMP response element-binding (CREB) protein in hippocampus. Mol Cell Endocrinol 382:227–233. doi:10.1016/j.mce.2013.09.037CrossRefPubMedGoogle Scholar
Tarnopolsky MA, Bourgeois JM, Snow R, Keys S, Roy BD, Kwiecien JM, Turnbull J (2003) Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats. Am J Physiol Regul Integr Comp Physiol 285:R762–R769. doi:10.1152/ajpregu.00270.2003CrossRefPubMedGoogle Scholar
Tayek JA, Istfan NW, Jones CT, Hamawy KJ, Bistrian BR, Blackburn GL (1986) Influence of the Walker 256 carcinosarcoma on muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res 46:5649–5654PubMedGoogle Scholar